Ipamorelin 50mg — Vial Spec, Reconstitution Math & COA

Overview of the Ipamorelin 50mg Research Mass Configuration

In enterprise-scale assay design, high-volume cell culture series, and extended animal model protocols, purchasing peptides in larger mass configurations minimizes lot-to-lot variance and reduces baseline recalibration overhead. An ipamorelin 50mg mass footprint caters specifically to research facilities conducting parallel microplate screens, automated liquid-handling operations, or continuous multi-subject preclinical trials where maintaining a single, homogeneous batch lot is vital for scientific rigor.

Ipamorelin (sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2) is a highly selective growth hormone secretagogue (GHS) that targets the growth hormone secretagogue receptor 1a (GHS-R1a). Unlike early-generation hexapeptides, its pentapeptide structure exhibits high specificity. When evaluating large-quantity formats, researchers must balance the economy of scale against aqueous degradation kinetics once reconstituted. Consequently, proper handling of a 50mg mass unit requires dedicated aliquot protocols immediately following lyophilate solubilization.

It is critical to note that PX1 Research prioritizes compound stability and minimal freeze-thaw degradation for laboratory workflows. While bulk custom quotes for 50mg raw material or specialized fills can be processed through our wholesale lab accounts, our standardized single-vial catalog features optimized unit sizes (such as 2mg, 5mg, and 10mg) on our primary Ipamorelin product page to guarantee maximum bioactivity and eliminate waste. Investigators requiring high-throughput supply can review our full all peptides inventory to coordinate custom fill schedules or multi-vial research allocations.

Receptor Selectivity and Preclinical Pharmacodynamics

In vitro binding assays indicate that ipamorelin binds to the GHS-R1a receptor with nanomolar affinity, mimicking the endogenous ligand ghrelin to stimulate growth hormone (GH) secretion from anterior pituitary somatotrophs. Preclinical studies suggest that the primary operational distinction of ipamorelin relative to other secretagogues is its absolute selectivity. In rodent and canine models, administration of ipamorelin elicited robust, dose-dependent GH pulses while maintaining baseline levels of adrenocorticotropic hormone (ACTH), cortisol, and prolactin.

This absence of secondary endocrine activation is attributed to ipamorelin's unique interaction with the extracellular domains of GHS-R1a, which fails to trigger the non-specific central nervous system pathways that drive stress-hormone signaling. In vitro data indicate that ipamorelin does not induce significant appetite stimulation signaling through hypothalamic NPY/AgRP pathways to the degree observed with native ghrelin, making it a valuable tool for isolating pure GH-mediated anabolic and metabolic signaling networks.

In longitudinal animal studies, researchers monitor growth hormone secretion profiles via sequential serum sampling. Because ipamorelin exhibits a relatively short terminal elimination half-life in rodent plasma (approximately 2 hours), researchers frequently utilize continuous micro-infusion or precise pulsatile dosing schedules to mirror endogenous physiological GH secretory patterns.

Reconstitution Mathematics for 50mg Lyophilized Mass

Reconstitution calculations for a high-mass vial differ significantly from smaller analytical sizes (e.g., 2mg or 5mg). Adding standard diluent volumes (such as 1mL to 3mL) to an ipamorelin 50mg powder cake yields high-concentration stock solutions that require careful volumetric pipette calibration during assay prep. To determine working concentration ($C$), divide total peptide mass ($M = 50\text{ mg}$) by the volume of added solvent ($V$).

Adding 1.0 mL of Bacteriostatic Water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4) results in a concentration of $50\text{ mg/mL}$ ($50\,\mu\text{g/}\mu\text{L}$). Adding 2.0 mL yields $25\text{ mg/mL}$ ($25\,\mu\text{g/}\mu\text{L}$), while adding 3.0 mL yields approximately $16.67\text{ mg/mL}$ ($16.67\,\mu\text{g/}\mu\text{L}$). For complex dilutions or non-standard diluent volumes, laboratory personnel should double-check target calculations using our interactive reconstitution calculator.

Because high mass concentrations (e.g., $50\text{ mg/mL}$) increase local viscosity and can alter osmotic pressure in microfluidic or cell culture systems, investigators typically prepare a primary stock solution at $10\text{ mg/mL}$ or $25\text{ mg/mL}$ using sterile diluent, followed by secondary working dilutions in assay-matched buffers immediately prior to plate seeding or animal trial administration.

Aliquot Planning and Long-Term Storage Protocols

Once an ipamorelin 50mg vial is reconstituted, repeated freeze-thaw cycles must be strictly avoided. Thermal cycling induces peptide aggregation, peptide bond hydrolysis, and loss of receptor-binding affinity. Immediately following full dissolution, the primary stock solution should be divided into single-use micro-aliquots (e.g., 50 \mu L to 200 \mu L) using sterile, polypropylene, low-binding microcentrifuge tubes.

For short-term operational use (under 7 days), reconstituted ipamorelin stock solutions stored in bacteriostatic water may be kept at 2°C to 8°C, protected from light exposure. For long-term preservation (up to 3–6 months), aliquoted working stocks must be flash-frozen in liquid nitrogen or dry ice/ethanol baths and immediately stored in a freezer maintained at -20°C or -80°C.

Lyophilized (unreconstituted) ipamorelin 50mg vials maintain optimal chemical stability when stored in dark, desiccated conditions at -20°C. Prior to reconstitution, vials should be allowed to equilibrate to ambient room temperature (20°C to 25°C) for 30 minutes to prevent moisture condensation inside the vial upon stopper puncture.

Comparative Analysis: Ipamorelin vs. Related Secretagogues

When designing preclinical GH axis trials, selecting the appropriate secretagogue class dictates receptor cross-reactivity and physiological outcomes. Ipamorelin belongs to the growth hormone releasing peptide (GHRP) class but demonstrates a significantly cleaner selectivity profile than earlier peptides. The table and analysis below compare ipamorelin with two related GHRPs and a GHRH analog.

Preclinical data show that GHRP-6 exhibits potent GH release but simultaneously induces marked appetite stimulation and mild cortisol/prolactin release due to broader central GHS-R engagement. Similarly, GHRP-2 demonstrates higher absolute GH potency than GHRP-6 but causes measurable elevations in systemic ACTH and cortisol. Conversely, ipamorelin matches or exceeds the GH release specificity of these compounds without triggering secondary stress hormone cascades.

Furthermore, researchers frequently contrast GHS-R agonists with growth hormone-releasing hormone (GHRH) analogs such as CJC-1295 no DAC. While ipamorelin activates the GHS-R1a receptor pathway, CJC-1295 binds to the distinct GHRH receptor. In preclinical literature, co-investigation of these two distinct signaling pathways demonstrates synergistic GH secretion, producing a far greater amplitude of pulsatile release than either compound class evaluated independently.

Catalog Availability and Custom Wholesale Options

While an ipamorelin 50mg single vial offers extreme volumetric economy, deploying such large single-vial masses carries risk: if a single 50mg container is contaminated or undergoes accidental thermal exposure during handling, the entire experimental block is compromised. For this reason, PX1 Research stocks pre-portioned unit sizes (2mg, 5mg, and 10mg) on our primary Ipamorelin product page.

Distributing total experimental mass across multiple 5mg or 10mg vials ensures that unused portions remain sealed in a dry, lyophilized state at -20°C until immediately needed. This modular approach preserves baseline purity across multi-week studies and prevents batch contamination.

For institutional laboratories, contract research organizations (CROs), and university departments requiring high-volume orders—including custom 50mg single-vial fills, specialized bulk packaging, or mass powder lots—PX1 Research provides tailored bulk fulfillment via our wholesale lab accounts program. All custom fills adhere to the same stringent manufacturing and testing protocols as our standard catalog items.

Analytical Quality Control: HPLC, Mass Spectrometry, and Endotoxin Limits

Quantitative integrity is essential when evaluating peptide compounds in cell culture or animal assays. PX1 Research subjects every production lot to comprehensive third-party analytical testing. High-Performance Liquid Chromatography (HPLC) is utilized to verify chemical purity, ensuring that every batch meets or exceeds our strict ≥98.0% purity threshold.

Mass Spectrometry (MS) analysis confirms the precise molecular weight of the ipamorelin peptide (711.86 g/mol), verifying sequence accuracy and the absence of truncation sequences or deletion fragments resulting from solid-phase peptide synthesis (SPPS). Additionally, all lots undergo Chromogenic Reagent Endotoxin Testing (LAL assay) to guarantee endotoxin levels remain strictly below <0.01 EU/mg, preventing confounding inflammatory responses in sensitive cell lines or rodent models.

Researchers can review batch-specific analytical documentation directly on our dedicated COA verification page. Transparent access to lot-matched HPLC chromatograms and MS spectra ensures complete reproducibility for publications and internal validation protocols. Learn more about our overall analytical methodologies across our primary research hub.

Standard Operating Procedure: Reconstitution and Handling in Vitro

To achieve maximum recovery and maintain chemical integrity during reconstitution of an ipamorelin 50mg vial, research personnel should adhere to the following standard operating procedure:

1. Remove the vial from cold storage (-20°C) and allow it to sit at room temperature for 30 minutes to eliminate moisture condensation inside the container. 2. Sanitize the rubber septum with a 70% isopropyl alcohol swab inside a certified laminar flow hood. 3. Using a sterile, low-retention syringe, draw up the calculated volume of diluent (e.g., Bacteriostatic Water or sterile 0.9% NaCl). 4. Aim the needle against the glass wall of the vial, allowing the diluent to trickle down slowly into the lyophilized cake. Avoid direct high-pressure jetting onto the powder. 5. Gently swirl the vial in a circular motion until completely dissolved. Do NOT shake or vortex vigorously, as mechanical shear forces can denature peptide secondary structures. 6. Draw the reconstituted solution into sterile polypropylene micro-tubes to create single-use aliquots, label each tube with lot number and concentration, and freeze immediately at -80°C.